All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Rodin Therapeutics Inc., a company co-founded by Proteros Biostructures GmbH and Atlas Venture, raised $12.9 million in a series A round to take forward two sets of epigenetic modulators that are in development for Alzheimer's disease.